169 related articles for article (PubMed ID: 8911642)
21. Protein Targets of Isoniazid-Reactive Metabolites in Mouse Liver in Vivo.
Koen YM; Galeva NA; Metushi IG; Uetrecht J; Hanzlik RP
Chem Res Toxicol; 2016 Jun; 29(6):1064-72. PubMed ID: 27097313
[TBL] [Abstract][Full Text] [Related]
22. Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis.
Dutt M; Khuller GK
Int J Antimicrob Agents; 2001 Feb; 17(2):115-22. PubMed ID: 11165115
[TBL] [Abstract][Full Text] [Related]
23. Hepatotoxicity mechanisms of isoniazid: A mini-review.
Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit.
Thomas BH; Whitehouse LW; Zeitz W
Fundam Appl Toxicol; 1984 Aug; 4(4):646-53. PubMed ID: 6479511
[TBL] [Abstract][Full Text] [Related]
25. Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats.
Metushi IG; Nakagawa T; Uetrecht J
Chem Res Toxicol; 2012 Nov; 25(11):2567-76. PubMed ID: 23016703
[TBL] [Abstract][Full Text] [Related]
26. Circadian variation in murine hepatotoxicity to the antituberculosis agent «Isoniazide».
Souayed N; Chennoufi M; Boughattas F; Haouas Z; Maaroufi K; Miled A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
Chronobiol Int; 2015; 32(9):1201-10. PubMed ID: 26479844
[TBL] [Abstract][Full Text] [Related]
27. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line.
Sanfeliu C; Wright JM; Kim SU
Neurotoxicology; 1999 Dec; 20(6):935-44. PubMed ID: 10693974
[TBL] [Abstract][Full Text] [Related]
28. The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10.
Baskaran UL; Sabina EP
Cell Biol Toxicol; 2015 Oct; 31(4-5):211-9. PubMed ID: 26374116
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway.
Jia ZL; Cen J; Wang JB; Zhang F; Xia Q; Wang X; Chen XQ; Wang RC; Hsiao CD; Liu KC; Zhang Y
Chemosphere; 2019 Jul; 227():541-550. PubMed ID: 31004821
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous quantitation of hydrazine and acetylhydrazine in human plasma by high performance liquid chromatography-tandem mass spectrometry after derivatization with p-tolualdehyde.
Song L; Gao D; Li S; Wang Y; Liu H; Jiang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():189-195. PubMed ID: 28881295
[TBL] [Abstract][Full Text] [Related]
31. Role of CYP3A in isoniazid metabolism in vivo.
Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X
Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716
[TBL] [Abstract][Full Text] [Related]
32. Effect of subacute administration of isoniazid and pyridoxine on lipids in plasma, liver and adipose tissues in the rabbit.
Karthikeyan S; Krishnamoorthy MS
Drug Chem Toxicol; 1991; 14(3):293-303. PubMed ID: 1935708
[TBL] [Abstract][Full Text] [Related]
33. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
[TBL] [Abstract][Full Text] [Related]
34. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid.
Cheng J; Krausz KW; Li F; Ma X; Gonzalez FJ
Toxicol Appl Pharmacol; 2013 Jan; 266(2):245-53. PubMed ID: 23142471
[TBL] [Abstract][Full Text] [Related]
35. Oxidation of hydrazine metabolites formed from isoniazid.
Lauterburg BH; Smith CV; Todd EL; Mitchell JR
Clin Pharmacol Ther; 1985 Nov; 38(5):566-71. PubMed ID: 3931954
[TBL] [Abstract][Full Text] [Related]
36. Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.
He L; Guo Y; Deng Y; Li C; Zuo C; Peng W
Xenobiotica; 2017 Feb; 47(2):154-163. PubMed ID: 28118809
[TBL] [Abstract][Full Text] [Related]
37. Isoniazid: metabolic aspects and toxicological correlates.
Preziosi P
Curr Drug Metab; 2007 Dec; 8(8):839-51. PubMed ID: 18220565
[TBL] [Abstract][Full Text] [Related]
38. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
Vuilleumier N; Rossier MF; Chiappe A; Degoumois F; Dayer P; Mermillod B; Nicod L; Desmeules J; Hochstrasser D
Eur J Clin Pharmacol; 2006 Jun; 62(6):423-9. PubMed ID: 16770646
[TBL] [Abstract][Full Text] [Related]
39. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
Timbrell JA
Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism.
Ramanathan R; Sivanesan K
Chem Biol Interact; 2017 Aug; 273():142-153. PubMed ID: 28619387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
